About 383,000 results
Open links in new tab
  1. Aldosterone: The Forgotten Hormone - Medscape

    Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but what is the optimal approach to regulating this hormone?

  2. Treatment of Preserved Cardiac Function Heart Failure With an ...

    Feb 24, 2014 · Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial. Program and abstracts of the American Heart Association Scientific Sessions …

  3. Aldosterone Hormone Linked to Alcohol Use, Cravings - Medscape

    Jul 25, 2017 · Novel findings show a link between the steroid hormone aldosterone and a risk for alcohol use disorder, underscoring the role of neuroendocrine mechanisms in alcohol cravings …

  4. Oral Semaglutide: Trends Suggest Potential Kidney Benefits

    Jun 17, 2025 · While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable formulation in the FLOW trial, the observed trends …

  5. Aldosterone Antagonists in the Treatment of Heart Failure

    Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with …

  6. Secondary Hypertension: What to Look For - Medscape

    Jul 16, 2025 · Low potassium with elevated blood pressure should prompt renin-aldosterone ratio. For pheochromocytoma, watch for episodic hypertension with palpitations, headaches, or …

  7. Semaglutide Significantly Improves Chronic Kidney Disease

    May 24, 2024 · The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD.

  8. Baxdrostat: A 'Game Changer' for Hypertension? - Medscape

    Aug 31, 2025 · A new class of antihypertensive agent that blocks the production of aldosterone has shown impressive results in patients with resistant or uncontrolled hypertension.

  9. Novel Drug Lowers Stubbornly High BP in Phase 3 Trial - Medscape

    Jun 30, 2025 · Lorundrostat, a novel aldosterone synthase inhibitor, lowered blood pressure among adults with uncontrolled hypertension in a phase 3 trial, including in treatment-resistant …

  10. Are You Screening for Primary Aldosteronism in Primary Care?

    Sep 12, 2025 · The guidelines suggest that all individuals with hypertension be screened for primary aldosteronism — by measuring aldosterone and renin and then determining the …